The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention
Abstract
The memory-enhancing potential of D-cycloserine (cycloserine) a partial agonist at the glycine recognition site on the NMDA receptor, was evaluated in mice using a thirst-motivated linear maze learning task. Immediate acute post-training injections (10, 20 and 80 mg/kg) significantly improved retention relative to vehicle-injected controls. Retention was also facilitated if cycloserine (3 and 10 mg/kg but not 20 or 40 mg/kg) was administered 20 min before the retention test. Acquisition of the habit was accelerated if cycloserine (3 mg/kg) was injected 20 min before the training session. Acute post-training injections failed to facilitate retention if mice were pretreated with cycloserine (3 mg/kg) b.i.d. for 15 days before training on the maze. These results indicate that acute cycloserine administration can enhance consolidation and retrieval of memory but that desensitization may occur with chronic exposure to the drug.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and because daily, longer-term dosing appears to reduce the cognitive enhancing effects of DCS (Quartermain et al, 1994), possibly due to desensitization of the NMDA receptor over time (Boje et al, 1993).”
From D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial (2014) · cites this paper as Quartermain et al, 1994
In the citing paper
“Studies reported by Parnas et al (2005) and Quartermain et al (1994) described the multiple administration of DCS before fear conditioning or the maze learning test, respectively (ie preadministration of DCS).”
From Effects of Single Prolonged Stress and D-Cycloserine on Contextual Fear Extinction and Hippocampal NMDA Receptor Expression in a Rat Model of PTSD (2008) · cites this paper as Quartermain et al (1994)
In the citing paper
“Similarly, Quartermain et al (1994) reported that chronic preexposure to DCS for 15 days led to a significant decrease in the effect of DCS upon the maze learning test (Quartermain et al, 1994).”
From Effects of Single Prolonged Stress and D-Cycloserine on Contextual Fear Extinction and Hippocampal NMDA Receptor Expression in a Rat Model of PTSD (2008) · cites this paper as Quartermain et al (1994)
Citations
Cites
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,182
Monaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,213
Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures.
Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6368 · Cited by 2,174
Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes
Kleckner, N. W., & Dingledine, R. J. (1988) · Science · doi:10.1126/science.2841759 · Cited by 1,427
NMDA receptors - their role in long-term potentiation
Collingridge, G. L., & Bliss, T. (1987) · Trends in Neurosciences · doi:10.1016/0166-2236(87)90175-5 · Cited by 1,178
Long-term potentiation and NMDA receptors in rat visual cortex
Artola, A., & Singer, W. (1987) · Nature · doi:10.1038/330649a0 · Cited by 967
Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex
Lei, S. Z., Pan, Z., Aggarwal, S. K., Chen, H.-S. V., Hartman, J., Sucher, N. J., & Lipton, S. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90130-6 · Cited by 740
Monaghan, D. T., Olverman, H. J., Nguyen, L., Watkins, J. C., & Cotman, C. W. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9836 · Cited by 490
d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics
Hood, W. F., Compton, R. P., & Monahan, J. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90379-0 · Cited by 309
Research works printed but not linked: 1
- Conzelman, 1956, On the physiological disposition of cycloserine in experimental animals, Am. Rev. Tuberc. Pulmonary Dis., 74, 802
Cited by
Sorted by citations
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Molecular mechanisms of memory reconsolidation
Tronson, N. C., & Taylor, J. R. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2090 · Cited by 810
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Danysz, W., & Parsons, C. G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01382-6 · Cited by 652
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560
Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work
Davis, M., Ressler, K., Rothbaum, B. O., & Richardson, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.084 · Cited by 498
Reconsolidation and Extinction of Conditioned Fear: Inhibition and Potentiation
Lee, J. L. C., Milton, A. L., & Everitt, B. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2466-06.2006 · Cited by 479
GOFF, D. C., Tsai, G. E., Levitt, J. J., AMICO, E. T., Manoach, D. S., Schoenfeld, D., Hayden, D. L., McCarley, R. W., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Finally, chronic DCS treatment leads to loss of effects on extinction, possibly via NMDAR desensitization (Parnas et al., 2005; Quartermain et al., 1994).”
BackgroundD-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder
Kushner, M. G., Kim, S. W., Donahue, C. B., THURAS, P. D., Adson, D. E., Kotlyar, M., McCabe, J., Peterson, J., & Foa, E. B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.020 · Cited by 384
Augmentation of Behavior Therapy With d -Cycloserine for Obsessive-Compulsive Disorder
Wilhelm, S., Buhlmann, U., Tolin, D. F., Meunier, S. A., Pearlson, G. D., Reese, H. E., Cannistraro, P., Jenike, M. A., & Rauch, S. L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07050776 · Cited by 358
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 303
Wistar rats show episodic-like memory for unique experiences
KARTTEKE, E., DESOUZASILVA, M., HUSTON, J., & DERE, E. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.10.002 · Cited by 250
Yamamoto, S., Morinobu, S., Fuchikami, M., Kurata, A., Kozuru, T., & Yamawaki, S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301605 · Cited by 224
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
CASALE, A. D., Sorice, S., Padovano, A., Simmaco, M., Ferracuti, S., Lamis, D. A., Rapinesi, C., Sani, G., Girardi, P., Kotzalidis, G. D., et al. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180813155017 · Cited by 243
de Kleine, R. A., Hendriks, G.-J., Kusters, W. J. C., Broekman, T. G., & van Minnen, A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.02.033 · Cited by 220
Difede, J., Cukor, J., Wyka, K., Olden, M., Hoffman, H., Lee, F. S., & Altemus, M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.317 · Cited by 212
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses
Won, H., Mah, W., & Kim, E. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00019 · Cited by 217
Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications
Richardson, R., Ledgerwood, L., & Cranney, J. (2004) · Learning & Memory · doi:10.1101/lm.78204 · Cited by 185
Pharmacological treatments that facilitate extinction of fear: Relevance to psychotherapy
Davis, M., Myers, K. M., Chhatwal, J., & Ressler, K. J. (2006) · NeuroRX · doi:10.1016/j.nurx.2005.12.008 · Cited by 174
Shaltiel, G., Hanan, M., Wolf, Y., Barbash, S., Kovalev, E., Shoham, S., & Soreq, H. (2012) · Brain Structure and Function · doi:10.1007/s00429-011-0376-z · Cited by 173
Effects of multiple exposures to d-cycloserine on extinction of conditioned fear in rats
Parnas, A. S., Weber, M. F., & Richardson, R. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.01.001 · Cited by 146
GOFF, D., CATHER, C., GOTTLIEB, J., EVINS, A., WALSH, J., RAEKE, L., OTTO, M., SCHOENFELD, D., & GREEN, M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.012 · Cited by 144
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
Schade, S., & Paulus, W. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv102 · Cited by 135
Enhancing exposure-based therapy from a translational research perspective
Hofmann, S. G. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.06.006 · Cited by 138
Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning
Todd, T. P., Vurbic, D., & Bouton, M. E. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.012 · Cited by 147
Augmentation Treatment of Psychotherapy for Anxiety Disorders with D‐Cycloserine
Hofmann, S. G., Pollack, M. H., & Otto, M. W. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00208.x · Cited by 123
NMDA receptors and fear extinction: implications for cognitive behavioral therapy
Davis, M. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.4/mdavis · Cited by 120
Kantrowitz, J. T., Epstein, M. L., Beggel, O., Rohrig, S. N., Lehrfeld, J. M., Revheim, N., Lehrfeld, N., Reep, J., Parker, E. M., Silipo, G. S., et al. (2016) · Brain · doi:10.1093/brain/aww262 · Cited by 115
Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis
Rodrigues, H., Figueira, I., Lopes, A., Gonçalves, R., Mendlowicz, M. V., Coutinho, E. S. F., & Ventura, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093519 · Cited by 109
Zhang, X.-L., Sullivan, J. A., Moskal, J. R., & Stanton, P. K. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.018 · Cited by 107
Wu, W. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(01)00009-5 · Cited by 104
Emotional Modulation of Learning and Memory: Pharmacological Implications
LaLumiere, R. T., McGaugh, J. L., & McIntyre, C. K. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013474 · Cited by 103
Synaptic plasticity in Alzheimer’s disease and healthy aging
Torres, D. M. C., & Cárdenas, F. P. (2020) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0058 · Cited by 101
Onur, O. A., Schlaepfer, T. E., Kukolja, J., Bauer, A., Jeung, H., Patin, A., Otte, D.-M., Shah, N. J., Maier, W., Kendrick, K. M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.022 · Cited by 97
Paolone, G., Botreau, F., & Stewart, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1280-y · Cited by 96
Yang, Y.-L., & Lu, K. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.003 · Cited by 93
Moskal, J. R., Kuo, A. G., Weiss, C., Wood, P. L., Hanson, A. O., Kelso, S. R., Harris, R. B., & Disterhoft, J. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.006 · Cited by 91
Olfactory bulb habituation to odor stimuli.
Chaudhury, D., Manella, L. C., Arellanos, A., Escanilla, O., Cleland, T. A., & Linster, C. (2010) · Behavioral Neuroscience · doi:10.1037/a0020293 · Cited by 97
Effects of low-dose d-serine on recognition and working memory in mice
Bado, P., Madeira, C., Vargas-Lopes, C., Moulin, T. C., Wasilewska‐Sampaio, A. P., Maretti, L., de Oliveira, R. V., Amaral, O. B., & Panizzutti, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2330-4 · Cited by 94
van Berckel, B. N. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00014-7 · Cited by 89
Bustos, S. G., Giachero, M., Maldonado, H., & Molina, V. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.215 · Cited by 91
Feld, G. B., & Jan Born, A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0490-9 · Cited by 84
Novel Approach to the Role of NMDA Receptors in Traumatic Brain Injury
Shohami, E., & Biegon, A. R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660196 · Cited by 80
Urbano, M. R., Okwara, L., Manser, P., Hartmann, K., Herndon, A. L., & Deutsch, S. I. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000033 · Cited by 75
A placebo-controlled study of sildenafil effects on cognition in schizophrenia
GOFF, D. C., Cather, C., Freudenreich, O., Henderson, D. C., Evins, A. E., Maravić, M. C., & Walsh, J. P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1278-5 · Cited by 76
Augmentation of exposure therapy with post-session administration of D-cycloserine
Tart, C. D., Handelsman, P. R., DeBoer, L. B., Rosenfield, D., Pollack, M. H., Hofmann, S. G., Powers, M. B., Otto, M. W., & Smits, J. A. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.09.024 · Cited by 75
Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia
Coyle, J. T., Balu, D. T., Benneyworth, M. A., Basu, A. C., & Roseman, A. S. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.3/jcoyle · Cited by 75
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia
Gottlieb, J. D., Cather, C., Shanahan, M., Creedon, T., Macklin, E. A., & Goff, D. C. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.029 · Cited by 73
Yang, Y.-L., Chao, P.-K., Ro, L., Wo, Y., & Lu, K.-T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301215 · Cited by 79
d-Cycloserine augmentation of cognitive remediation in schizophrenia
Cain, C. K., McCue, M. G., Bello, I., Creedon, T. B., Tang, D., LASKA, E. M., & GOFF, D. C. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.01.016 · Cited by 75
Enhancement of psychosocial treatment with D-cycloserine: Models, moderators, and future directions
Otto, M. W., Kredlow, M. A., Smits, J. A. J., Hofmann, S. G., Tolin, D. F., de Kleine, R. A., van Minnen, A., Evins, A. E., & Pollack, M. H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.007 · Cited by 70
The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders
Peyrovian, B., Rosenblat, J. D., Pan, Z., Iacobucci, M., Brietzke, E. M., & McIntyre, R. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.001 · Cited by 76
Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms
Coyle, J. T. (2006) · Neurotoxicity Research · doi:10.1007/bf03033359 · Cited by 71
Rouaud, E., & Billard, J. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705541 · Cited by 65
D-Cycloserine: An Evolving Role in Learning and Neuroplasticity in Schizophrenia
GOFF, D. C. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs012 · Cited by 65
Land, C., & Riccio, D. C. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3897 · Cited by 61
Involvement of the NMDA System in Learning and Memory
Rezvani, A. H. (2006) · Frontiers in neuroscience · doi:10.1201/9781420004335.ch4 · Cited by 61
Maurice, T., Lockhart, B. P., Su, T., & Privat, A. (1996) · Brain Research · doi:10.1016/0006-8993(96)00710-x · Cited by 60
D-Cycloserine: Agonist turned antagonist
Lanthorn, T. H. (1994) · Amino Acids · doi:10.1007/bf00813745 · Cited by 60
Self-citationd-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
Hofmann, S. G., Wu, J. Q., & Boettcher, H. (2013) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-3-11 · Cited by 59
Thompson, L. T., & Disterhoft, J. F. (1997) · Behavioral Neuroscience · doi:10.1037/0735-7044.111.6.1303 · Cited by 57
d-Cycloserine Facilitates Extinction of Conditioned Alcohol-Seeking Behaviour in Rats
Vengeliene, V., Kiefer, F., & Spanagel, R. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn067 · Cited by 57
Assessment of Pharmacotherapy for Negative Symptoms of Schizophrenia
Hanson, E., Healey, K. M., Wolf, D. H., & Kohler, C. G. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0148-0 · Cited by 61
The Role of Serine Racemase in the Pathophysiology of Brain Disorders
Coyle, J. T., & Balu, D. T. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.10.002 · Cited by 58
Glycine Site Agonists of the NMDA Receptor: A Review
D’Souza, D. C., Charney, D. S., & Krystal, J. H. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00285.x · Cited by 57
D-cycloserine and cocaine cue reactivity: preliminary findings
Price, K. L., McRae-Clark, A. L., Saladin, M. E., Maria, M. M. M.-S., DeSantis, S. M., Back, S. E., & Brady, K. T. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990903384332 · Cited by 54
Otto, M. W., Basden, S. L., Leyro, T. M., McHugh, R. K., & Hofmann, S. G. (2007) · CNS Spectrums · doi:10.1017/s1092852900020526 · Cited by 53
Price, K. L., Baker, N. L., McRae‐Clark, A. L., Saladin, M. E., DeSantis, S. M., Ana, E. J. S., & Brady, K. T. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2592-x · Cited by 55
Effects of d ‐Cycloserine on Extinction and Reconditioning of Ethanol‐Seeking Behavior in Mice
Groblewski, P. A., Lattal, K. M., & Cunningham, C. L. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00895.x · Cited by 52
Geekiyanage, H., Upadhye, A., & Chan, C. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.001 · Cited by 52
Evaluation of Cycloserine in the Treatment of Alzheimer's Disease
Fakouhi, T. D., Jhee, S. S., Sramek, J. J., Benes, C. O., Schwartz, P., Hantsburger, G., Herting, R. L., Swabb, E. A., & Cutler, N. R. (1995) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198879500800405 · Cited by 51
Self-citationKochlamazashvili, G., Bukalo, O., Senkov, O., Salmen, B., Gerardy‐Schahn, R., Engel, A. K., Schachner, M., & Dityatev, A. E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-11.2012 · Cited by 49
Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators
Yao, L., & Zhou, Q. (2017) · Neural Plasticity · doi:10.1155/2017/2875904 · Cited by 50
Park, J. M., Small, B. J., GELLER, D. A., Murphy, T. K., Lewin, A. B., & Storch, E. A. (2013) · Journal of Child and Family Studies · doi:10.1007/s10826-013-9742-1 · Cited by 49
D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach
MacKillop, J., Few, L. R., Stojek, M. M., Murphy, C. M., Malutinok, S. F., Johnson, F. T., Hofmann, S. G., McGeary, J. E., Swift, R. M., & Monti, P. M. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.41 · Cited by 46
Calcium Channel Antagonists Enhance Retention of Passive Avoidance and Maze Learning in Mice
Quartermain, D., deSoria, V. G., & Kwan, A. (2001) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1999.3958 · Cited by 46
Self-citationMeyer, R. C., Knox, J. J., Purwin, D. A., Spangler, E. L., & Ingram, D. K. (1998) · Psychopharmacology · doi:10.1007/s002130050512 · Cited by 42
Optimizing behavior therapy for youth with Tourette’s disorder
Mcguire, J. F., Ginder, N. D., Ramsey, K. A., Essoe, J. K.-Y., Ricketts, E. J., McCracken, J. T., & Piacentini, J. C. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0762-4 · Cited by 41
Kantrowitz, J. T. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.003 · Cited by 40
Thwaites, D. T., Armstrong, G., Hirst, B. H., & Simmons, N. L. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14998.x · Cited by 41
Drug development in schizophrenia
GOFF, D. C. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000152 · Cited by 40
GOFF, D. C. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160225154812 · Cited by 40
Barak, S., & Weiner, I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009176 · Cited by 39
Strategies That Support Declining Cholinergic Neurotransmission in Alzheimer’s Disease Patients
Sirviö, J. (1999) · Gerontology · doi:10.1159/000052759 · Cited by 40
Urbano, M. R., Okwara, L., Manser, P., Hartmann, K., & Deutsch, S. I. (2015) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13070155 · Cited by 43
White, T. L., Monnig, M. A., Walsh, E. G., Nitenson, A. Z., Harris, A. D., Cohen, R. A., Porges, E. C., Woods, A. J., Lamb, D. G., Boyd, C. A., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0027-7 · Cited by 38
Sartori, S. B., Maurer, V., Murphy, C. P., Schmuckermair, C., Muigg, P., Neumann, I. D., Whittle, N., & Singewald, N. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv128 · Cited by 37
The partial NMDA agonist D -cycloserine stimulates LH secretion in healthy volunteers
van Berckel, B. N. M., Lipsch, C., Wied, C. C. G., Wynne, H. J. A., Blankenstein, M. A., van Ree, J. M., & Kahn, R. S. (1998) · Psychopharmacology · doi:10.1007/s002130050662 · Cited by 36
Using visual lateralization to model learning and memory in zebrafish larvae
Andersson, M. Å., Ek, F., & Olsson, R. (2015) · Scientific Reports · doi:10.1038/srep08667 · Cited by 33
Forsyth, J. K., Bachman, P., Mathalon, D. H., Roach, B. J., Ye, E. M., & Asarnow, R. F. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw193 · Cited by 34
Effects of D-cycloserine and Aniracetam on Spatial Learning in Rats with Entorhinal Cortex Lesions
Zajaczkowski, W., & Danysz, W. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00133-5 · Cited by 33
Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans
Rockstroh, S., Emre, M., Pokorny, R., & Tarral, A. (1996) · Psychopharmacology · doi:10.1007/bf02246666 · Cited by 33
Pussinen, R., & Sirviö, J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300210 · Cited by 33
Tresserra, M. P., Martí‐Nicolovius, M., Tarrés-Gatius, M., Candalija, A., Guillazo‐Blanch, G., & Vale-Martı́nez, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4858-z · Cited by 30
Peterson, S. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)01026-2 · Cited by 31
Facilitation of extinction of operant behaviour in mice by d-cycloserine
Shaw, D., Norwood, K., Sharp, K., Quigley, L., McGovern, S. F. J., & Leslie, J. C. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1312-7 · Cited by 30
Metadata
- Authors
- Quartermain, D., Mower, J., Rafferty, M. F., Herting, R. L., & Lanthorn, T. H.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Quartermain, David
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 1994-05
- Volume
- 257
- Issue
- 1-2
- Pages
- 7-12
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W1989766588
- Cited by
- 190
- References
- 26
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 12 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 4 · 2017: 9 · 2016: 4 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 10
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- D-cycloserine, NMDA receptor, glycine receptor, partial agonists, memory enhancement, learning and retention, memory consolidation, memory retrieval, desensitization, chronic drug exposure, acute drug administration
- MeSH terms
- Analysis of Variance, Animals, Behavior, Animal, Cycloserine, Drug Administration Schedule, Learning, Male, Memory, Receptors, N-Methyl-D-Aspartate, Receptors, Glycine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review